CD44 and breast cancer: By using a xenograft model, Al-Hajj et al. demonstrated that as few as 200 sorted and passaged CD44+CD24−/low breast cancer stem cells had the ability to produce tumors that could be serially transplanted in NOD/SCID mice (46).